Assessment of the Impact of Comorbidities on Outcomes in Non-ST Elevation Myocardial Infarction (NSTEMI) Patients: A
Bryan Felix1, Fawaz Aldoohan2, Hansanee U Kadirage3
1Medical Student, Avalon University School of Medicine, Los Angeles, USA.
Insights
Non-ST-segment elevation myocardial infarction (NSTEMI) impacts patients with common comorbidities like hypertension and diabetes. Understanding these interactions is key to improving NSTEMI patient care and outcomes.
Area of Science:
- Cardiology
- Internal Medicine
- Public Health
Background:
- Non-ST-segment elevation myocardial infarction (NSTEMI) presents significant morbidity and mortality.
- NSTEMI is characterized by elevated cardiac biomarkers without ST-segment elevation, often indicating a poorer prognosis.
- Common comorbidities frequently coexist with NSTEMI, complicating treatment and worsening outcomes.
Purpose of the Study:
- To investigate the impact of comorbidities on NSTEMI patients.
- To examine the prevalence of hypertension (HTN), diabetes mellitus (DM), COPD, obesity, dyslipidemia, and smoking in NSTEMI patients.
- To understand how these comorbidities affect NSTEMI treatment protocols and patient prognosis.
Main Methods:
- Comprehensive literature review.
- Analysis of existing data on NSTEMI patients and their comorbidities.
- Examination of individual comorbidity prevalence within the NSTEMI population.
Main Results:
- Data analysis reveals the prevalence of specific comorbidities in NSTEMI patients.
- The study identifies how conditions like HTN, DM, and COPD interact with NSTEMI.
- Established NSTEMI treatment protocols are evaluated for their effectiveness in the presence of comorbidities.
Conclusions:
- Comorbidities significantly influence NSTEMI patient prognosis and treatment.
- Optimizing clinical decision-making requires understanding the interplay between NSTEMI and comorbidities.
- Enhanced patient care strategies are crucial for improving outcomes in this high-risk group.
Abstract:
Non-ST-segment elevation myocardial infarction (NSTEMI) is associated with significant morbidity and mortality, occurring when the heart's need for oxygen cannot be met. It is defined by elevated cardiac biomarkers without ST-segment elevation and often carries a poorer prognosis than most ST-segment elevation events. NSTEMI usually results from severe coronary artery narrowing, transient occlusion, or microembolization of thrombus/atheromatous material. Patients with NSTEMI often have multiple comorbidities, which can worsen their prognosis and complicate treatment. This study aims to investigate the impact of comorbidities such as hypertension (HTN), diabetes mellitus (DM), chronic obstructive pulmonary disease (COPD), obesity, dyslipidemia, and smoking on patients with NSTEMI. The prevalence of each comorbidity is examined individually within the NSTEMI population to provide a clearer picture of how frequently these conditions co-occur with NSTEMI and how they affect the established NSTEMI treatment protocols. This paper sheds light on the interaction between NSTEMI and commonly associated comorbidities through a comprehensive literature review and data analysis. This is critical for optimizing clinical decision-making and enhancing patient care, ultimately improving outcomes in this high-risk patient population.
More Related Videos
18:11A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
Published on: December 28, 2012
14:35Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
Related Concept Videos
01:15Methods of Documentation VI: Case Management Model
For example, a patient with a chronic...
01:22Nursing Diagnosis
The nursing diagnosis focuses on evidence-based...
01:10Documentation of Nursing Diagnosis
In some settings, data-driven computerized decision support systems are in place, allowing for more accurate nursing diagnoses. The database within one of these systems includes diagnostic labels defining characteristics, activities, and indicators for nursing. A nurse enters...
01:23Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
01:17Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
01:15Nursing Evaluation